Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial.
about
Benefits of antioxidant supplements for knee osteoarthritis: rationale and realityThe spice for joint inflammation: anti-inflammatory role of curcumin in treating osteoarthritisReduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative RandomizedIsothiocyanates are detected in human synovial fluid following broccoli consumption and can affect the tissues of the knee jointAnalgesic Efficacy and Safety of Curcuminoids in Clinical Practice: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Chondroprotective effects of Salubrinal in a mouse model of osteoarthritis.Curcumin attenuates brain edema in mice with intracerebral hemorrhage through inhibition of AQP4 and AQP9 expression.Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.Decrease of serum biomarker of type II Collagen degradation (Coll2-1) by intra-articular injection of an autologous plasma-rich-platelet in patients with unilateral primary knee osteoarthritis.Anti-inflammatory effects of polyphenols in arthritis.Curcumin and normal functioning of joints: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.Curcumin-loaded nanoliposomes linked to homing peptides for integrin targeting and neuropilin-1-mediated internalization.
P2860
Q28071711-28825262-DF6A-41F8-AF1C-05C981A1A18EQ28076995-8D3D4514-1694-42C9-B748-96736C7158FDQ33733817-F5F6346A-7FC5-48CA-B9F9-4A70E590D742Q33794384-D6179085-23F3-4AEF-88A1-09CF9FFE2154Q34675414-1F438B79-A47C-485E-A0D6-594B144B5FD8Q35644533-62C4163F-D839-453D-BE01-CA2CECC94C76Q36044826-CEEAC11B-08FA-497C-B7E8-3C7FAE730F80Q38957154-927F4099-A263-42FA-8507-B3F43C4FDD25Q42199082-D4AA35FE-E933-4C3F-B6F9-A261D84A0A96Q46310171-6415305B-FA60-419F-B55E-326709F7680AQ47159374-13B078E4-1512-4361-9F2C-4B106953B9E9Q49639609-3C404BB9-2F01-4EAD-90B7-04AFC7FE9B6DQ51019313-C667C7DA-6AED-4B22-A40F-0520A52ABDB1
P2860
Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Decrease of a specific biomark ...... an exploratory clinical trial.
@ast
Decrease of a specific biomark ...... an exploratory clinical trial.
@en
type
label
Decrease of a specific biomark ...... an exploratory clinical trial.
@ast
Decrease of a specific biomark ...... an exploratory clinical trial.
@en
prefLabel
Decrease of a specific biomark ...... an exploratory clinical trial.
@ast
Decrease of a specific biomark ...... an exploratory clinical trial.
@en
P2093
P2860
P921
P356
P1476
Decrease of a specific biomark ...... an exploratory clinical trial.
@en
P2093
Adelin Albert
Caroline Castermans
Elisabeth Heuse
Fabian Priem
Laurence Seidel
Marc Marty
Myriam Gharbi
Valérie Bonnet
Yvan Dierckxsens
Yves Henrotin
P2860
P2888
P356
10.1186/1472-6882-14-159
P577
2014-05-17T00:00:00Z
P5875
P6179
1048650802